Sex-specific control of central nervous system autoimmunity by p38 mitogen-activated protein kinase signaling in myeloid cells

Annals of Neurology

Volumn 75, Issue 1, 2014, Pages 50-66

  Krementsov, Dimitry N ^a   Noubade, Rajkumar ^a,b   Dragon, Julie A ^a   Otsu, Kinya ^c   Rincon, Mercedes ^a   Teuscher, Cory ^a  

^a UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

^b GENENTECH INC   (United States)

^c KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMALS; AUTOIMMUNITY; CELLS, CULTURED; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; ENZYME ACTIVATION; FEMALE; MALE; MAP KINASE SIGNALING SYSTEM; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, TRANSGENIC; MITOGEN-ACTIVATED PROTEIN KINASE 14; MYELOID CELLS; P38 MITOGEN-ACTIVATED PROTEIN KINASES; SEX CHARACTERISTICS;

EID: 84894029692     PISSN: 03645134     EISSN: 15318249     Source Type: Journal    
DOI: 10.1002/ana.24020     Document Type: Article

References (68)

1. Ramagopalan SV, Sadovnick AD,. Epidemiology of multiple sclerosis. Neurol Clin 2011; 29: 207-217.
2. Greenstein JI,. Current concepts of the cellular and molecular pathophysiology of multiple sclerosis. Dev Neurobiol 2007; 67: 1248-1265.
3. Sawcer S, Hellenthal G, Pirinen M, et al. Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis. Nature 2011; 476: 214-219.
4. Ebers GC,. Environmental factors and multiple sclerosis. Lancet Neurol 2008; 7: 268-277.
5. Rincon M, Davis RJ,. Regulation of the immune response by stress-activated protein kinases. Immunol Rev 2009; 228: 212-224.
6. Lee JC, Laydon JT, McDonnell PC, et al. A protein kinase involved in the regulation of inflammatory cytokine biosynthesis. Nature 1994; 372: 739-746.
7. Liverton NJ, Butcher JW, Claiborne CF, et al. Design and synthesis of potent, selective, and orally bioavailable tetrasubstituted imidazole inhibitors of p38 mitogen-activated protein kinase. J Med Chem 1999; 42: 2180-2190.
8. Hollenbach E, Neumann M, Vieth M, et al. Inhibition of p38 MAP kinase- and RICK/NF-kappaB-signaling suppresses inflammatory bowel disease. FASEB J 2004; 18: 1550-1552.
9. Ando H, Kurita S, Takamura T,. The specific p38 mitogen-activated protein kinase pathway inhibitor FR167653 keeps insulitis benign in nonobese diabetic mice. Life Sci 2004; 74: 1817-1827.
10. Genovese MC,. Inhibition of p38: has the fat lady sung? Arthritis Rheum 2009; 60: 317-320.
11. Hammaker D, Firestein GS,. "Go upstream, young man": lessons learned from the p38 saga. Ann Rheum Dis 2010; 69 (suppl 1): i77-i82.
12. Cho JH, Gregersen PK,. Genomics and the multifactorial nature of human autoimmune disease. N Engl J Med 2011; 365: 1612-1623.
13. Shin T, Ahn M, Jung K, et al. Activation of mitogen-activated protein kinases in experimental autoimmune encephalomyelitis. J Neuroimmunol 2003; 140: 118-125.
14. Lock C, Hermans G, Pedotti R, et al. Gene-microarray analysis of multiple sclerosis lesions yields new targets validated in autoimmune encephalomyelitis. Nat Med 2002; 8: 500-508.
15. Lu L, Wang J, Zhang F, et al. Role of SMAD and non-SMAD signals in the development of Th17 and regulatory T cells. J Immunol 2010; 184: 4295-4306.
16. Noubade R, Krementsov DN, Del Rio R, et al. Activation of p38 MAPK in CD4 T cells controls IL-17 production and autoimmune encephalomyelitis. Blood 2011; 118: 3290-3300.
17. Namiki K, Matsunaga H, Yoshioka K, et al. Mechanism for p38alpha-mediated experimental autoimmune encephalomyelitis. J Biol Chem 2012; 287: 24228-24238.
18. Huang G, Wang Y, Vogel P, et al. Signaling via the kinase p38alpha programs dendritic cells to drive TH17 differentiation and autoimmune inflammation. Nat Immunol 2012; 13: 152-161.
19. Jirmanova L, Giardino Torchia ML, Sarma ND, et al. Lack of the T cell-specific alternative p38 activation pathway reduces autoimmunity and inflammation. Blood 2011; 118: 3280-3289.
20. Guo X, Harada C, Namekata K, et al. Regulation of the severity of neuroinflammation and demyelination by TLR-ASK1-p38 pathway. EMBO Mol Med 2010; 2: 504-515.
21. Clausen BE, Burkhardt C, Reith W, et al. Conditional gene targeting in macrophages and granulocytes using LysMcre mice. Transgenic Res 1999; 8: 265-277.
22. Caton ML, Smith-Raska MR, Reizis B,. Notch-RBP-J signaling controls the homeostasis of CD8- dendritic cells in the spleen. J Exp Med 2007; 204: 1653-1664.
23. Nishida K, Yamaguchi O, Hirotani S, et al. p38alpha mitogen-activated protein kinase plays a critical role in cardiomyocyte survival but not in cardiac hypertrophic growth in response to pressure overload. Mol Cell Biol 2004; 24: 10611-10620.
24. Lee PP, Fitzpatrick DR, Beard C, et al. A critical role for Dnmt1 and DNA methylation in T cell development, function, and survival. Immunity 2001; 15: 763-774.
25. Noubade R, Milligan G, Zachary JF, et al. Histamine receptor H1 is required for TCR-mediated p38 MAPK activation and optimal IFN-gamma production in mice. J Clin Invest 2007; 117: 3507-3518.
26. Benjamini Y, Hochberg Y,. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc Series B Stat Methodol 1995; 57: 289-300.
27. Spence RD, Voskuhl RR,. Neuroprotective effects of estrogens and androgens in CNS inflammation and neurodegeneration. Front Neuroendocrinol 2012; 33: 105-115.
28. Segal BM,. Th17 cells in autoimmune demyelinating disease. Semin Immunopathol 2010; 32: 71-77.
29. Rincon M, Enslen H, Raingeaud J, et al. Interferon-gamma expression by Th1 effector T cells mediated by the p38 MAP kinase signaling pathway. EMBO J 1998; 17: 2817-2829.
30. Chastain EM, Duncan DS, Rodgers JM, Miller SD,. The role of antigen presenting cells in multiple sclerosis. Biochim Biophys Acta 2011; 1812: 265-274.
31. Izikson L, Klein RS, Luster AD, Weiner HL,. Targeting monocyte recruitment in CNS autoimmune disease. Clin Immunol 2002; 103: 125-131.
32. Ponomarev ED, Shriver LP, Maresz K, Dittel BN,. Microglial cell activation and proliferation precedes the onset of CNS autoimmunity. J Neurosci Res 2005; 81: 374-389.
33. Marta M, Meier UC, Lobell A,. Regulation of autoimmune encephalomyelitis by toll-like receptors. Autoimmun Rev 2009; 8: 506-509.
34. Oksenberg JR, Hauser SL,. Decoding multiple sclerosis. Ann Neurol 2011; 70: A5-A7.
35. Gourraud PA, Harbo HF, Hauser SL, Baranzini SE,. The genetics of multiple sclerosis: an up-to-date review. Immunol Rev 2012; 248: 87-103.
36. Park JM, Greten FR, Wong A, et al. Signaling pathways and genes that inhibit pathogen-induced macrophage apoptosis-CREB and NF-kappaB as key regulators. Immunity 2005; 23: 319-329.
37. Kim C, Sano Y, Todorova K, et al. The kinase p38 alpha serves cell type-specific inflammatory functions in skin injury and coordinates pro- and anti-inflammatory gene expression. Nat Immunol 2008; 9: 1019-1027.
38. Greten FR, Arkan MC, Bollrath J, et al. NF-kappaB is a negative regulator of IL-1beta secretion as revealed by genetic and pharmacological inhibition of IKKbeta. Cell 2007; 130: 918-931.
39. Rosenberg GA,. Matrix metalloproteinases in neuroinflammation. Glia 2002; 39: 279-291.
40. Carrier Y, Ma HL, Ramon HE, et al. Inter-regulation of Th17 cytokines and the IL-36 cytokines in vitro and in vivo: implications in psoriasis pathogenesis. J Invest Dermatol 2011; 131: 2428-2437.
41. Tortola L, Rosenwald E, Abel B, et al. Psoriasiform dermatitis is driven by IL-36-mediated DC-keratinocyte crosstalk. J Clin Invest 2012; 122: 3965-3976.
42. Vigne S, Palmer G, Lamacchia C, et al. IL-36R ligands are potent regulators of dendritic and T cells. Blood 2011; 118: 5813-5823.
43. Guan H, Fan D, Mrelashvili D, et al. MicroRNA let-7e is associated with the pathogenesis of experimental autoimmune encephalomyelitis. Eur J Immunol 2013; 43: 104-114.
44. Rottman JB, Slavin AJ, Silva R, et al. Leukocyte recruitment during onset of experimental allergic encephalomyelitis is CCR1 dependent. Eur J Immunol 2000; 30: 2372-2377.
45. Musgrave T, Benson C, Wong G, et al. The MAO inhibitor phenelzine improves functional outcomes in mice with experimental autoimmune encephalomyelitis (EAE). Brain Behav Immun 2011; 25: 1677-1688.
46. O'Brien M, Lonergan R, Costelloe L, et al. OAS1: a multiple sclerosis susceptibility gene that influences disease severity. Neurology 2010; 75: 411-418.
47. Fedetz M, Matesanz F, Caro-Maldonado A, et al. OAS1 gene haplotype confers susceptibility to multiple sclerosis. Tissue Antigens 2006; 68: 446-449.
48. Cagliani R, Fumagalli M, Guerini FR, et al. Identification of a new susceptibility variant for multiple sclerosis in OAS1 by population genetics analysis. Hum Genet 2012; 131: 87-97.
49. Rott O, Fleischer B, Cash E,. Interleukin-10 prevents experimental allergic encephalomyelitis in rats. Eur J Immunol 1994; 24: 1434-1440.
50. Cua DJ, Sherlock J, Chen Y, et al. Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain. Nature 2003; 421: 744-748.
51. Godl K, Wissing J, Kurtenbach A, et al. An efficient proteomics method to identify the cellular targets of protein kinase inhibitors. Proc Natl Acad Sci U S A 2003; 100: 15434-15439.
52. Spach KM, Noubade R, McElvany B, et al. A single nucleotide polymorphism in Tyk2 controls susceptibility to experimental allergic encephalomyelitis. J Immunol 2009; 182: 7776-7783.
53. Blankenhorn EP, Butterfield RJ, Rigby R, et al. Genetic analysis of the influence of pertussis toxin on experimental allergic encephalomyelitis susceptibility: an environmental agent can override genetic checkpoints. J Immunol 2000; 164: 3420-3425.
54. Matsuki T, Nakae S, Sudo K, et al. Abnormal T cell activation caused by the imbalance of the IL-1/IL-1R antagonist system is responsible for the development of experimental autoimmune encephalomyelitis. Int Immunol 2006; 18: 399-407.
55. Guma M, Hammaker D, Topolewski K, et al. Antiinflammatory functions of p38 in mouse models of rheumatoid arthritis: advantages of targeting upstream kinases MKK-3 or MKK-6. Arthritis Rheum 2012; 64: 2887-2895.
56. Clark AR, Dean JL, Saklatvala J,. Post-transcriptional regulation of gene expression by mitogen-activated protein kinase p38. FEBS Lett 2003; 546: 37-44.
57. Schindler JF, Monahan JB, Smith WG,. p38 pathway kinases as anti-inflammatory drug targets. J Dent Res 2007; 86: 800-811.
58. Oertelt-Prigione S,. The influence of sex and gender on the immune response. Autoimmun Rev 2012; 11: A479-A485.
59. Imahara SD, Jelacic S, Junker CE, O'Keefe GE,. The influence of gender on human innate immunity. Surgery 2005; 138: 275-282.
60. Sheikh-Hamad D, Gustin MC,. MAP kinases and the adaptive response to hypertonicity: functional preservation from yeast to mammals. Am J Physiol Renal Physiol 2004; 287: F1102-F1110.
61. Cowan KJ, Storey KB,. Mitogen-activated protein kinases: new signaling pathways functioning in cellular responses to environmental stress. J Exp Biol 2003; 206 (pt 7): 1107-1115.
62. Muthusamy V, Piva TJ,. The UV response of the skin: a review of the MAPK, NFkappaB and TNFalpha signal transduction pathways. Arch Dermatol Res 2010; 302: 5-17.
63. Orton SM, Wald L, Confavreux C, et al. Association of UV radiation with multiple sclerosis prevalence and sex ratio in France. Neurology 2011; 76: 425-431.
64. Norval M, McLoone P, Lesiak A, Narbutt J,. The effect of chronic ultraviolet radiation on the human immune system. Photochem Photobiol 2008; 84: 19-28.
65. Hauser SL, Weiner HL, Che M, et al. Prevention of experimental allergic encephalomyelitis (EAE) in the SJL/J mouse by whole body ultraviolet irradiation. J Immunol 1984; 132: 1276-1281.
66. Becklund BR, Severson KS, Vang SV, DeLuca HF,. UV radiation suppresses experimental autoimmune encephalomyelitis independent of vitamin D production. Proc Natl Acad Sci U S A 2010; 107: 6418-6423.
67. Kleinewietfeld M, Manzel A, Titze J, et al. Sodium chloride drives autoimmune disease by the induction of pathogenic T17 cells. Nature 2013; 496: 518-522.
68. Wu C, Yosef N, Thalhamer T, et al. Induction of pathogenic T17 cells by inducible salt-sensing kinase SGK1. Nature 2013; 496: 513-517.